RSRaoul Saggini

Raoul Saggini

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Raoul Saggini has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effects of Mechano-Sonic Vibration Therapy on Muscle Strength, Pain, and Joint Function in Elderly Patients Undergoing Total Knee and Hip Arthroplasty: A Retrospective, Case-Control Study

    by Raoul Saggini, Domiziano Tarantino, Claudia Barbato, Raffaello Pellegrino, Francesco Pegreffi, Rosa Grazia Bellomo

    Background: Early recovery after total hip (THA) and total knee arthroplasty (TKA) is often limited by pain and impaired antigravity function. Mechano-acoustic vibration therapy (VT) may enhance neuromuscular activation and analgesia, but evidence in arthroplasty is scarce. Methods: A total of 380 patients aged ≥65 years were retrospectively identified within 3 ± 1 days after primary unilateral total hip arthroplasty (THA) or total knee arthroplasty (TKA). All patients underwent standard inpatient physiotherapy; in the VT group, mechano-acoustic vibration therapy (ViSS®, 30 min/day for 5 days at 200–300 Hz) was added as an adjunct treatment, whereas the control group received standard physiotherapy alone. Pain (VAS, McGill), muscle strength (MRC), thigh circumferences, and 10 s Sit-to-Stand were assessed at baseline (T0), end of treatment (T1), and 3-day follow-up (T2). Results: VT produced large, early and sustained improvements in both cohorts. In THA patients, VAS decreased from 7.1 ± 1.1 to 3.8 ± 0.6 at T1 and 3.0 ± 0.7 at T2 and Sit-to-Stand repetitions increased from 3.7 ± 1.9 to 6.3 ± 1.7 at T2, with significant gains in strength and circumferences. TKA VT patients showed similar patterns. Control groups reported smaller pain reductions and no clinically relevant changes in the reported outcomes. Conclusions: integrating a short cycle of mechano-acoustic VT into early inpatient rehabilitation after THA or TKA significantly enhances pain relief and restoration of antigravity function compared with standard physiotherapy alone. VT represents a promising adjunct to conventional rehabilitation strategies and may contribute to optimizing postoperative recovery pathways in major joint replacement.

  • Open Access

    Effects Of Mechano-Sonic Vibration Therapy on Muscle Strength, Pain, And Joint Function in Elderly Patients Undergoing Total Knee and Hip Arthroplasty: A Retrospective, Case-Control Study

    by Raoul Saggini, Domiziano Tarantino, Claudia Barbato, Raffaello Pellegrino, Francesco Pegreffi, Rosa Grazia Bellomo

    Background Early recovery after total hip (THA) and total knee arthroplasty (TKA) is often limited by pain and impaired antigravity function. Mechano-acoustic vibration therapy (VT) may enhance neuromuscular activation and analgesia, but evidence in arthroplasty is scarce. Methods 380 patients ≥65 years were included within 3±1 days after primary unilateral total hip arthroplasty (THA) (n=200) or total knee arthroplasty (TKA) (n=180) and received either mechano-acoustic VT (ViSS®, 30 min/day for 5 days at 200–300 Hz; THA n=100, TKA n=90) or standard physiotherapy alone (90 min/day; matched controls THA n=100, TKA n=90). Pain (NRS/VAS, McGill), quadriceps strength (MRC), thigh circumferences and 10-s Sit-to-Stand were assessed at baseline (T0), end of treatment (T1) and 3-day follow-up (T2). Results VT produced large, early and sustained improvements in both cohorts. In THA patients, VAS decreased from 7.1±1.1 to 3.8±0.6 at T1 and 3.0±0.7 at T2 and Sit-to-Stand repetitions increased from 3.7±1.9 to 6.3±1.7 at T2, with significant gains in strength and circumferences. TKA VT patients showed similar patterns. Control groups reported smaller pain reductions and no clinically relevant changes in the reported outcomes. Conclusions Integrating a short cycle of mecha-no-acoustic VT into early inpatient rehabilitation after THA or TKA significantly en-hances pain relief and restoration of antigravity function compared with standard physiotherapy alone. VT represents a promising adjunct to conventional rehabilitation strategies and may contribute to optimizing postoperative recovery pathways in major joint replacement.

  • Open Access

    Clinical Benefits and Safety of Polynucleotides Injections for the Treatment of Painful Tendinopathies: A Multicenter, Single-Cohort, Retrospective Study

    by Domiziano Tarantino, Luca Ruosi, Angelo Di Iorio, Raoul Saggini, Raffaello Pellegrino

    Background: Tendons, along with joints, are among the most affected structures in musculoskeletal disorders. This multicenter, single-cohort, retrospective clinical study evaluated the clinical benefits of Polynucleotides (PNs) injections in reducing pain and improving functionality in patients with tendinopathies. Methods: This retrospective study included 68 patients with different tendinopathies, all diagnosed with persistent pain lasting at least six weeks, accompanied by functional impairment and swelling. Three periarticular/peritendinous injections of a PNs-based medical device were administered at T0 (baseline), FU-1 (two weeks post-T0), and FU-2 (four weeks post-T0), with efficacy and safety assessments at FU-1, FU-2, FU-3 (eight weeks post-FU-2), and FU-4 (24 weeks post-FU-2) groups. The primary outcome measure was pain reduction, assessed using a numerical rating scale (NRS). Secondary outcomes were the Clinical Global Impression–Improvement scale (CGI-I), and patient satisfaction using a 5-point Likert scale. Results: Longitudinal analysis showed an average NRS score reduction of -1.76±0.08 at each follow-up, with statistically significant reductions observed between each follow-up and the final one (FU-4). Based on the CGI-I scale, 78% of the clinicians rated the clinical condition of tendinopathies at FU-4 as "very much improved" or "much improved." Additionally, 88% of patients reported being "satisfied" or "very satisfied" with treatment at the final follow-up (FU-4). No adverse events were reported. Conclusions: As demonstrated by the positive outcomes reported in this study, PNs injections may offer a promising therapeutic option for the treatment of tendinopathies. This study may open up new frontiers for the implementation of conservative approaches in patients affected by tendinopathies.